Depreciation of Atara Biotherapeutics, Inc. from 31 Dec 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Atara Biotherapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2013 to 31 Mar 2025.
  • Atara Biotherapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $300,000, a 67% decline year-over-year.
  • Atara Biotherapeutics, Inc. Depreciation for the twelve months ending 31 Mar 2025 was $300,000, a 92% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Depreciation for 2024 was $900,000, a 76% decline from 2023.
  • Atara Biotherapeutics, Inc. annual Depreciation for 2023 was $3,700,000, a 21% decline from 2022.
  • Atara Biotherapeutics, Inc. annual Depreciation for 2022 was $4,700,000.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Atara Biotherapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $300,000 $300,000 -$600,000 -67% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $900,000 $1,300,000 -$2,300,000 -230% 01 Oct 2024 31 Dec 2024 10-Q 15 May 2025 2025 Q1
Q3 2024 $3,200,000 $600,000 -$300,000 -33% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $3,500,000 $700,000 -$200,000 -22% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $3,700,000 $900,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $3,700,000 $1,000,000 +$300,000 +43% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $3,400,000 $900,000 -$200,000 -18% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $3,600,000 $900,000 -$500,000 -36% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $4,100,000 $900,000 -$600,000 -40% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $4,700,000 $700,000 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $1,100,000 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $1,400,000 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $1,500,000 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2017 $206,000 +$191,000 +1273% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q1 2016 $15,000 +$9,000 +150% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q1 2015 $6,000 +$5,000 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q1 2014 $1,000* 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1

Atara Biotherapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $900,000 -$2,800,000 -76% 01 Jan 2024 31 Dec 2024 10-Q 15 May 2025 2025 Q1
2023 $3,700,000 -$1,000,000 -21% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
2022 $4,700,000 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2016 $383,000 +$335,000 +698% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2017 2016 FY
2015 $48,000 +$42,000 +700% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2017 2016 FY
2014 $6,000 +$2,000 +50% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
2013 $4,000 01 Jan 2013 31 Dec 2013 10-K 04 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.